C
Capricor Therapeutics, Inc.
CAPR · NASDAQ · Healthcare · 382M
Closing price
$7.83
-2.25% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.2×
Enterprise value / EBITDAEV/EBITDA
-0.9×
Free cash flow yieldFCF yield
-20.0%
Return on equityROE
-34.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.7×
Interest coverage
-35.5×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.